Does early liver cancer need immunotherapy after surgery? Pay attention to these two points in the early treatment of liver cancer

Whether immunotherapy is needed after surgery for early liver cancer needs to be judged based on the situation. If the patient has a low possibility of recurrence after surgery, immunotherapy is not needed; if the patient has a high possibility of recurrence after surgery or has already recurred after surgery, immunotherapy is needed.

1. Not required:

Patients with early-stage liver cancer should be treated with surgical resection in a timely manner to reduce the possibility of cancer cells spreading or metastasizing to other parts of the body. If the possibility of recurrence after surgery is relatively low, immunotherapy is generally not needed.

2. Requirement:

Some patients may experience cancer metastasis to other parts of the body in the early stages, which may lead to a high possibility of recurrence after surgery. Or if the patient has already relapsed after surgery, immunotherapy is needed to help control the progression of the disease.

It is recommended that patients with early liver cancer go to a regular hospital for evaluation and actively cooperate with treatment according to the doctor's advice to avoid delaying the disease. At the same time, patients should avoid fatigue in their daily lives, exercise moderately, quit smoking and drinking, avoid spicy and irritating foods, and maintain a good mental state.